These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7161597)

  • 1. Preparation and evaluation of a zonal purified influenza vaccine Gripax.
    Levy R; Zakay-Rones Z
    J Med Virol; 1982; 10(4):265-72. PubMed ID: 7161597
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular response in humans following vaccination with Gripax influenza virus.
    Shapira-Nahor O; Morag A; Levy R; Zakay-Rones Z
    J Med Virol; 1982; 10(1):75-80. PubMed ID: 7130968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccines purified by zonal ultracentrifugation.
    Filczak K; Semkow R; Wrzos H; Zakrzewski K; Zgorzelska K
    Acta Microbiol Pol A; 1973; 5(3):261-70. PubMed ID: 4769561
    [No Abstract]   [Full Text] [Related]  

  • 4. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM; McCahon D; Freestone DS
    Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of "Alice" influenza virus vaccine in normal healthy adults.
    Zaky DA; Douglas RG; Betts RF; Roth FK; Rinehart CJ; Hogan PW
    J Infect Dis; 1976 Jun; 133(6):669-75. PubMed ID: 946973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Obtaining a lyophilized preparation of inactivated influenza vaccine].
    Goriunova VV; Bichurina MA; Gerasimov VA
    Tr Inst Im Pastera; 1979; 52():110-4. PubMed ID: 550533
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of a microfiltration method in producing inactivated influenza vaccine].
    Ivanov NB; Zhemkov VP; Gromov VI; Cherkasov AN; Shashkov LA
    Vopr Virusol; 1986; 31(4):404-9. PubMed ID: 3765563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Host antigens in purified preparations of the influenza virus].
    Zhebrun AB; Polianskaia NIu; Noskov FS; Fridman EA
    Tr Inst Im Pastera; 1982; 59():70-81. PubMed ID: 7187572
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibility of preparing inactivated influenza vaccine by a combination of gel chromatography and ultrafiltration].
    Fridman AL; Ermolaev AI; Bichurina MA; Polianskaia NIu; Zheleznova NV
    Tr Inst Im Pastera; 1979; 52():103-7. PubMed ID: 550531
    [No Abstract]   [Full Text] [Related]  

  • 13. Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines.
    Davenport FM; Hennessy AV; Maassab HF; Minuse E; Clark LC; Abrams GD; Mitchell JR
    J Infect Dis; 1977 Jul; 136(1):17-25. PubMed ID: 69670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-Turkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus.
    Beard CW; Easterday BC
    Avian Dis; 1973; 17(1):173-81. PubMed ID: 4697709
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Virology; 1976 Feb; 69(2):511-22. PubMed ID: 1258359
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inactivated vaccine against trivalent influenza. Comparative study of the immune response by hemagglutination inhibition and simple radial hemolysis methods].
    Mancini DA; do Nascimento EM; Tavares VR; Lucchiari MA; Prado JA; Soares MA
    Rev Saude Publica; 1985 Oct; 19(5):438-43. PubMed ID: 3915399
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children.
    Murphy BR; Richman DD; Spring SB; Chanock RM
    Postgrad Med J; 1976 Jun; 52(608):381-8. PubMed ID: 785430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological and physicochemical principles of producing killed influenza vaccines].
    Fridman EA; Kolikov VM; Peradze TV
    Tr Inst Im Pastera; 1976; 47():7-13. PubMed ID: 1052953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.